Search

Your search keyword '"Stavudine -- Evaluation"' showing total 14 results
Start Over Descriptor "Stavudine -- Evaluation" Publisher newsrx llc
14 results on '"Stavudine -- Evaluation"'

1. Novel stavudine derivative active against resistant viral strains

Subjects
HIV infection -- Drug therapy, Stavudine -- Evaluation, Drug resistance in microorganisms
Abstract

2002 DEC 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A derivative of the antiretroviral agent stavudine is effective against HIV strains resistant to its [...]

Published
2002

2. Study Addresses Antiviral Efficacy

Subjects
HIV infection, Stavudine -- Evaluation, Zidovudine -- Evaluation
Abstract

1999 NOV 1 - (NewsRx.com) -- Recent study findings from Belgium may explain why d4T prodrugs, but not AZT prodrugs, retain anti-HIV activity in HIV infected thymidine kinase-deficient cell cultures. [...]

Published
1999

3. FDA Approves New Indications for Zerit and Videx

Subjects
Zerit (Medication) -- Licensing agreements, Videx (Medication) -- Licensing agreements, Stavudine -- Evaluation, Didanosine -- Evaluation
Abstract

(CW HENDERSON PUBLISHER www.newsfile.com) -- Bristol-Myers Squibb, Princeton, New Jersey, announced that the U.S. Food and Drug Administration (FDA) has approved new indications for Zerit (also known as d4T) and [...]

Published
1999

4. D4T PLUS DDI IS EFFECTIVE IN PEDIATRIC HIV

Author

Boyles, Salynn

Subjects
HIV infection in children -- Drug therapy, Stavudine -- Evaluation, Didanosine -- Evaluation, Biological sciences, Health
Abstract

(CW HENDERSON PUBLISHER www.newsfile.com) -- Therapy combining stavudine with didanosine appears to be useful in the treatment of pediatric HIV. 'This combination of nucleoside antiretroviral agents may provide a valuable [...]

Published
1999

5. d4T Plus DDI is Effective in Pediatric HIV

Author

Boyles, Salynn

Subjects
HIV infection in children -- Drug therapy, Stavudine -- Evaluation, Didanosine -- Evaluation
Abstract

(CW HENDERSON PUBLISHER www.newsfile.com) -- Therapy combining stavudine with didanosine appears to be useful in the treatment of pediatric HIV. "This combination of nucleoside antiretroviral agents may provide a valuable [...]

Published
1999

6. Combined Therapy Stavudine/Didanosine Effective in HIV+ Patients

Subjects
HIV infection -- Drug therapy, Stavudine -- Evaluation, Didanosine -- Evaluation
Abstract

Combination therapy with stavudine and didanosine appears to be safe and effective in HIV infected patients who have been treated previously with other antiretroviral agents. In this study, researcher F. [...]

Published
1998

7. Stavudine (d4T) Deficiency Not Due to Prior Retrovir Use

Subjects
Stavudine -- Evaluation, Zidovudine -- Health aspects, Viremia -- Measurement
Abstract

In a study presented at the 12th International AIDS Conference, held in Geneva, Switzerland, June 28 - July 3, 1998, researchers reported that the likelihood of HIV patients to achieve [...]

Published
1998

8. Combination Therapy with Dideoxyinosine (ddI) + Stavudine (d4T) is Superior to Dideoxyinosine + Epivir (3-TC) in Zidovudine (AZT) Experienced HIV Infected Children

Subjects
HIV infection in children -- Drug therapy, Didanosine -- Evaluation, Stavudine -- Evaluation, Drug therapy, Combination -- Evaluation
Abstract

"Combination Therapy with Dideoxyinosine (ddI) + Stavudine (d4T) is Superior to Dideoxyinosine + Epivir (3-TC) in Zidovudine (AZT) Experienced HIV Infected Children." S.A. Choudhury and G. Krishnamurthy. Interfaith Medical Center, [...]

Published
1998

9. European Study Suggests d4T/ddI Superiority Over AZT/3TC

Subjects
Zerit (Medication) -- Evaluation, Videx (Medication) -- Evaluation, HIV infection -- Drug therapy, Drug therapy, Combination -- Evaluation, Stavudine -- Evaluation, Didanosine -- Evaluation
Abstract

A European study has confirmed the dual nucleoside analogue combination of d4T (stavudine, Zerit) and ddI (didanosine, Videx) is associated with greater improvements in viral load and CD4+ counts than [...]

Published
1998

11. A Randomized Double-Blind Study of Stavudine and Didanosine Versus Zidovudine and Didanosine as Initial Treatment in HIV Infected Subjects With CD4 Count <=500 Cells/mm(3)

Subjects
Stavudine -- Evaluation, Didanosine -- Health aspects, Zidovudine -- Evaluation, Drug therapy, Combination -- Evaluation
Abstract

"A Randomized Double-Blind Study of Stavudine and Didanosine Versus Zidovudine and Didanosine as Initial Treatment in HIV Infected Subjects With CD4 Count According to an abstract submitted by the authors [...]

Published
1998

13. Conference Coverage (Retrovirus) d4T As Good as AZT in 3TC Combo - But PI Still Needed

Subjects
Stavudine -- Evaluation, Zidovudine -- Evaluation, Lamivudine -- Health aspects, Drug therapy, Combination -- Evaluation, Protease inhibitors -- Health aspects
Abstract

As an initial therapy, stavudine (d4T) works as well as zidovudine (AZT) in combination with lamivudine (3TC) - but a protease inhibitor (PI) should be added for maximum effect. AIDS [...]

Published
1998

14. Conference Coverage (Retrovirus) Message to Docs: Don't Give d4T plus AZT

Subjects
Stavudine -- Evaluation, Zidovudine -- Evaluation, Drug therapy, Combination -- Evaluation
Abstract

The anti-HIV drugs stavudine (d4T, Bristol Myers) and zidovudine (AZT, Glaxo) should not be used together, clinical trial results show. The data also show that d4T is far less effective [...]

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results